Correlation of bilirubin glucuronidation and estradiol-3-glucuronidation by UGT1A1: studies with model inhibitors

被引：0
作者：
Zhou, Jin [1 ]
Tracy, Timothy S. [1 ]
Remmel, Rory P. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN 55455 USA
来源：
DRUG METABOLISM REVIEWS | 2009年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38
    Paoluzzi, L
    Singh, AS
    Price, DK
    Danesi, R
    Mathijssen, RHJ
    Verweij, J
    Figg, WD
    Sparreboom, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (08) : 854 - 860
  • [22] A Humanized UGT1 Mouse Model Expressing the UGT1A1*28 Allele for Assessing Drug Clearance by UGT1A1-Dependent Glucuronidation
    Cai, Hongliang
    Nguyen, Nghia
    Peterkin, Vincent
    Yang, Young-Sun
    Hotz, Kathy
    La Placa, Deirdre Beaton
    Chen, Shujuan
    Tukey, Robert H.
    Stevens, Jeffrey C.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 879 - 886
  • [23] Glucuronidation of piceatannol by human liver microsomes: major role of UGT1A1, UGT1A8 and UGT1A10
    Miksits, Michaela
    Maier-Salamon, Alexandra
    Thanh Phuong Nha Vo
    Sulyok, Michael
    Schuhmacher, Rainer
    Szekeres, Thomas
    Jaeger, Walter
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (01) : 47 - 54
  • [24] Pharmacokinetics of riluzole: Evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype
    van Kan, H. J. M.
    van den Berg, L. H.
    Groeneveld, G. J.
    van der Straaten, R. J. H. M.
    van Vught, P. W. J.
    Lie-A-Huen, L.
    Guchelaar, H. -J.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2008, 29 (03) : 139 - 144
  • [25] Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients
    Wang, Ling-Zhi
    Ramirez, Jacqueline
    Yeo, Winnie
    Chan, Mei-Yi Michelle
    Thuya, Win-Lwin
    Lau, Jie-Ying Amelia
    Wan, Seow-Ching
    Wong, Andrea Li-Ann
    Zee, Ying-Kiat
    Lim, Robert
    Lee, Soo-Chin
    Ho, Paul C.
    Lee, How-Sung
    Chan, Anthony
    Ansher, Sherry
    Ratain, Mark J.
    Goh, Boon-Cher
    PLOS ONE, 2013, 8 (01):
  • [26] Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9
    Chen, Yakun
    Xie, Shenggu
    Chen, Shuqing
    Zeng, Su
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (03) : 416 - 425
  • [27] Genetic mutations in human UGT1A1 enhancer and SN-38 glucuronidation.
    Innocenti, F
    Grimsley, C
    DiRienzo, A
    Das, S
    Ramirez, J
    Chandler, J
    Ratain, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P104 - P104
  • [28] UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers
    Graber, Andrea L. Yoder
    Ramirez, Jacqueline
    Innocenti, Federico
    Ratain, Mark J.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (08) : 619 - 627
  • [29] Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism
    Iyer, L
    Hall, D
    Das, S
    Mortell, MA
    Ramírez, J
    Kim, S
    Di Rienzo, A
    Ratain, MJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (05) : 576 - 582
  • [30] Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10
    Ramirez, Jacqueline
    Mirkov, Snezana
    House, Larry K.
    Ratain, Mark J.
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (07) : 928 - 935
12345